“No question about it…this was a homerun,” said Michael Dixon, CEO and President at UNeMed, the event’s primary host.
The inaugural MidWest Drug Development Conference pulled together a dozen Midwestern universities, which represented more than $4.6 billion in research expenditures and 1,787 new inventions in 2016, according to the most recent data available. Those 12 universities presented 41 new, drug-related technologies in short, 10-minutes packages. The audience was a collection of pharmaceutical executives, venture capital groups and other potential partners who could help further develop those new technologies.
The goal of the Midwest Drug Development conference is to provide industry and investors a single event to learn about cutting edge Midwestern therapeutic technologies and start-up companies.
The 2018 MWDD conference will offer feature technologies from most major Midwestern universities, including Nebraska and the Nebraska Medical Center, Kansas, Kansas State, Iowa, Iowa State, Indiana, Ohio State, Oklahoma, Purdue, Washington University, and Colorado State.
Ample spaces dedicated to networking will be available for university, industry and investor guests who want to engage in one-on-one partnering discussions regarding their technologies.
OMAHA, Nebraska (January 30, 2019)—Due to the overall success and popularity of the inaugural MidWest Drug Development Conference last year, the event will return for a second year and registrations are now open, planners announced today.
The conference will again span two days, featuring Midwestern university technologies, beginning on Monday, Sept. 31, and concluding the following day, Tuesday, Oct. 1. The same venue—the Capital District Marriott in downtown Omaha—will house the event.
OMAHA, Nebraska (December 11, 2018)—The final results are in, and the inaugural MidWest Drug Development Conference was an unqualified success, UNeMed announced today.
“No question about it,” said Michael Dixon, CEO and President at UNeMed, the event’s primary host. “Taking a swing at something major like this is more than a little nerve-wracking. Will anyone show up? Are we wasting our time? But this was a home run, no doubt—and not just for us.”
As the first-ever Midwest Drug Development Conference winds down, please take a moment to help us learn where we went wrong, where we went right and how to improve the event for next year, or even if the event is worth repeating. It’s only 10 questions and should only take about four minutes.
Hotel website: http://www.downtownomahamarriott.com/
Event Coordinators
matt@mwdrugdevelopment.com | 402-559-2468
michael@mwdrugdevelopment.com | 402-559-2468
